Abstract:The effect of dendritic cell (DC) immunotherapy on non-small cell lung cancer (NSCLC) and its influence on the distribution of DC subsets were studied. Peripheral blood was drawn from 55 patients, and DCs were cultured in vitro and injected into the patients three times. The changes in DC subsets in NSCLC patients before treatment and after three treatments were observed using a flow cytometer, and the difference in DC subsets between patients and healthy controls was compared. DC subsets in lung cancer tissues, para-carcinoma tissues and normal tissues were analyzed by indirect immunofluorescence and laser scanning confocal microscope (LSCM). The BDCA-1+ DC1 and BDCA-3+ DC2 in lung cancer tissues were significantly increased compared with those in para-carcinoma tissues and normal tissues (P<0.05). The number of DC1 and DC2 in para-carcinoma tissues were increased compared with those in normal tissues (P<0.05). The ratio of DC1 in peripheral blood in the normal control group was obviously higher than that in NSCLC patients (P<0.01). There were significant differences in DC1 and DC1/DC2 ratio in NSCLC patients with different tumor staging, and there were also obvious differences in patients with a different Karnofsky performance status (KPS) score. Moreover, compared with those before treatment, DC1 and DC1/DC2 ratio were significantly increased after three treatments, and there was a significant difference in the comparison of DC1/DC2 ratio between the NSCLC patients with survival time greater than and less than one year. The immune function of NSCLC patients was improved after DC immunotherapy. The survival time of NSCLC patients was closely associated with the DC1/DC2 ratio in peripheral blood. The detection of DC subsets in peripheral blood can help clinicians understand the immune function of NSCLC patients and provide a basis for the clinical judgment of prognosis of NSCLC patients.

Experimental study on enhancement of immune function of dendritic cells from peripheral blood of patients with bladder cancer by blocking the B7-H1 pathway

Phenotype and metergasis of dendritic cells from peripheral blood of bladder carcinoma patients

The Immunity Effect of B7-H1 Blockade on Immature Dendritic Cells

Therapeutic Effect of MIP-1alpha-recruited Dendritic Cells on Preestablished Solid and Metastatic Tumors.

Silencing B7-H1 Enhances the Anti-Tumor Effect of Bladder Cancer Antigen-Loaded Dendritic Cell Vaccine in Vitro

Anti-bladder Cancer Effect in Vitro of Novel Dendritic Cell Vaccine Modified with B7-H1 Short Hairpin RNA and Pulsed with Tumor Antigen

Effect of PD-L1 Blockade on Function of Dendritic Cells Derived from Chronic Myelocytic Leukemia

Functional Expression of B7H1 on Pancreatic Carcinoma Panc-1 Cells

Dendritic cells derived from peripheral blood monocytes of patients with malignant tumor:a study of in vitro activity and function

Expression of dendritic cells on bladder transitional cell cacinoma and its dinical significance

Influence on Biological Characteristics of Dendritic Cells by Transfecting B7-H1 Antisense Gene

Inhibitory effects of dendritic cell (DC) vaccine loading antigen with irradiated apoptotic MB49 tumor cells against bladder cancer cells in mice

Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model

Reduction of Major Histocompatibility Complex Class I Expression on Bladder Carcinoma Following Tumor Antigen‐pulsed Dendritic Cell Vaccine: Implications for Immunoresistance in Therapy

[Changes in the Immune Function of Dendritic Cells (DC) Derived from HBV-related Hepatocellular Carcinoma (HCC) Patient's Peripheral Blood Monocytes (PBMC) Pulsed with Tumor Antigen].

Selective Blockade of B7‐H3 Enhances Antitumour Immune Activity by Reducing Immature Myeloid Cells in Head and Neck Squamous Cell Carcinoma

OVEREXPRESSION OF B7-H4 IN TUMOR INFILTRATED DENDRITIC CELLS

AG490 Reverses Phenotypic Alteration of Dendritic Cells by Bladder Cancer Cells.

Effects of DC on Immune Funtion of Postperative Patients with Rectalcolon Cancer

Effect of dendritic cell immunotherapy on distribution of dendritic cell subsets in non-small cell lung cancer

Costimulatory Molecule B7-H1 on the Immune Escape of Bladder Cancer and Its Clinical Significance.